Introducing a Tumour Agnostic Pre-Targeted Radiotherapeutic Platform to Target Tumour Associated Macrophages

  •  Pretargeting to increase therapeutic windows in RLTs
  • OncoOne’s Pretarg-it® platform
  • Data from preclinical tumor models and outlook